Epigenomics AG (FRA:ECX)
0.8800
-0.0300 (-3.30%)
At close: Oct 9, 2026
| Market Cap | 771.74K +0.0% |
| Revenue (ttm) | 30.00K +172.7% |
| Net Income | -238.00K |
| EPS | -0.27 |
| Shares Out | 876.98K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,813 |
| Open | 0.9100 |
| Previous Close | 0.9100 |
| Day's Range | 0.8750 - 0.9100 |
| 52-Week Range | 0.8400 - 1.5900 |
| Beta | 0.90 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 9, 2026 |